CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs
Healthcare Law Blog
FEBRUARY 22, 2023
The Rebate Programs are administered as part of the prescription drug affordability provisions of the Inflation Reduction Act (the “IRA”), which is aimed at “lower[ing] out-of-pocket drug costs for people with Medicare and improv[ing] the sustainability of the Medicare program for current and future generations.” [1]
52 
Let's personalize your content